Evidence for a founder effect in Sicilian patients with glycogen storage disease type II

Fabio Dagnino, Marina Stroppiano, Stefano Regis, Gloria Bonuccelli, Mirella Filocamo

Research output: Contribution to journalArticle

Abstract

Glycogen storage disease type II (GSD II) is an autosomal recessive inherited disorder due to the deficiency of the enzyme acid α-glucosidase, which causes an accumulation of glycogen in lysosomes. The deletion of exon 18 (Δ18) is a frequent mutation associated with a severe phenotype. We analyzed 25 Italian patients, 5 of whom were found to be Δ18 carriers. All these 5 patients came from Catania, a town in Sicily. We report on the analysis of 5 intragenic single-point polymorphic markers in the Δ18 patients and on the subsequent characterization of a Δ18-associated haplotype. The frequency of this haplotype in GSD II patients and normal individuals was 1 and 0.196, respectively (χ2 = 20.9; p <0.001). The high frequency of the Δ18 allele in this Italian subpopulation is likely to be due to a founder effect. Copyright (C) 2000 S. Karger AG, Basel.

Original languageEnglish
Pages (from-to)331-333
Number of pages3
JournalHuman Heredity
Volume50
Issue number6
Publication statusPublished - Nov 2000

Keywords

  • Δ18 deletion
  • Founder effect
  • Glycogen storage disease type II

ASJC Scopus subject areas

  • Genetics(clinical)

Fingerprint Dive into the research topics of 'Evidence for a founder effect in Sicilian patients with glycogen storage disease type II'. Together they form a unique fingerprint.

  • Cite this